139 related articles for article (PubMed ID: 23958399)
21. [Comprehensive use of clofelin and triampur compositum in treating hypertension].
Panikarskiĭ VG
Vrach Delo; 1981 Feb; (2):56-7. PubMed ID: 7222612
[No Abstract] [Full Text] [Related]
22. Antiproteinuric and blood pressure-lowering effects of a fixed-dose combination of losartan and hydrochlorothiazide in hypertensive patients with stage 3 chronic kidney disease.
Abe M; Okada K; Maruyama T; Matsumoto K
Pharmacotherapy; 2009 Sep; 29(9):1061-72. PubMed ID: 19698011
[TBL] [Abstract][Full Text] [Related]
23. [Acute kidney failure caused by triamterene and hydrochlorothiazide].
Heitmann D; Rumpf KW; Scheler F
Dtsch Med Wochenschr; 1982 May; 107(21):836. PubMed ID: 7075507
[No Abstract] [Full Text] [Related]
24. [On the bioavailability of hydrochlorothiazide and triamterene from commercial drugs (author's transl)].
Knauf H; Möhrke W; Mutschler E; Völger KD
Arzneimittelforschung; 1980; 30(6):1001-4. PubMed ID: 7191258
[TBL] [Abstract][Full Text] [Related]
25. [Comparative study of potassium-sparing effects of triamterene and amiloride in the treatment with hydrochlorothiazide].
Glezer GA; Merzon AK; Lipko DS; Donskova TV; Levinzon AM; Shelest IuP
Klin Med (Mosk); 1990 Sep; 68(9):61-4. PubMed ID: 2290332
[TBL] [Abstract][Full Text] [Related]
26. Hypertension therapy.
Caralis PV
South Med J; 1986 Jun; 79(6):781. PubMed ID: 3715548
[No Abstract] [Full Text] [Related]
27. Pharmacokinetics of a fixed combination with propranolol, hydrochlorothiazide and triamterene.
Felder K; Geissler HE; Hiemstra S; Mutschler E; Schäfer M; Ziegler E
Arzneimittelforschung; 1979; 29(11):1746-52. PubMed ID: 543886
[TBL] [Abstract][Full Text] [Related]
28. Clinical and pathological characterization of Mesoamerican nephropathy: a new kidney disease in Central America.
Wijkström J; Leiva R; Elinder CG; Leiva S; Trujillo Z; Trujillo L; Söderberg M; Hultenby K; Wernerson A
Am J Kidney Dis; 2013 Nov; 62(5):908-18. PubMed ID: 23850447
[TBL] [Abstract][Full Text] [Related]
29. Lithium intoxication and its clinical management.
Demers RG; Rivenbark JF
South Med J; 1982 Jun; 75(6):738-9. PubMed ID: 6965275
[No Abstract] [Full Text] [Related]
30. [Thiazide diuretic-induced subacute cutaneous lupus erythematosus].
Wollenberg A; Meurer M
Hautarzt; 1991 Nov; 42(11):709-12. PubMed ID: 1837545
[No Abstract] [Full Text] [Related]
31. Tubulointerstitial injury associated with chemotherapeutic agents.
Shirali AC; Perazella MA
Adv Chronic Kidney Dis; 2014 Jan; 21(1):56-63. PubMed ID: 24359987
[TBL] [Abstract][Full Text] [Related]
32. The spectrum of acute renal failure in IgA nephropathy.
Wen YK; Chen ML
Ren Fail; 2010 May; 32(4):428-33. PubMed ID: 20446779
[TBL] [Abstract][Full Text] [Related]
33. Comparative efficacy and bioequivalence of a brand-name and a generic triamterene-hydrochlorothiazide combination product.
Sharoky M; Perkal M; Tabatznik B; Cane RC; Costello K; Goodwin P
Clin Pharm; 1989 Jul; 8(7):496-500. PubMed ID: 2752698
[TBL] [Abstract][Full Text] [Related]
34. Drug-induced crystal nephropathy: an update.
Yarlagadda SG; Perazella MA
Expert Opin Drug Saf; 2008 Mar; 7(2):147-58. PubMed ID: 18324877
[TBL] [Abstract][Full Text] [Related]
35. Triamterene nephrolithiasis.
Dooley DP; Callsen ME; Geiling JA
Mil Med; 1989 Mar; 154(3):126-7. PubMed ID: 2496337
[TBL] [Abstract][Full Text] [Related]
36. Hyponatraemia induced by a combination of hydrochlorothiazide and triamterene.
Roberts CJ; Channer KS; Bungay D
Br Med J (Clin Res Ed); 1984 Jun; 288(6435):1962. PubMed ID: 6428623
[No Abstract] [Full Text] [Related]
37. Absence of a significant pharmacokinetic interaction between hydrochlorothiazide and triamterene when coadministered.
Upton RA; Williams RL; Lin ET; Gee WL; Blume CD; Benet LZ
J Pharmacokinet Biopharm; 1984 Dec; 12(6):575-86. PubMed ID: 6533293
[TBL] [Abstract][Full Text] [Related]
38. Treatment of mild-to-moderate hypertension: comparison between a calcium-channel blocker and a potassium-sparing diuretic.
Boulet AP; Chockalingam A; Fodor JG; Laplante L; Houde M; Lenis J; Logan AG; Robitaille MN; Ryan D; Spénard J
J Cardiovasc Pharmacol; 1991; 18 Suppl 9():S45-50. PubMed ID: 1725543
[TBL] [Abstract][Full Text] [Related]
39. Effects of muzolimine and of a combination of hydrochlorothiazide/triamterene in healthy subjects and in nephrotic patients.
Riechers G; Futerova M; Hanisch M; Ritter W; Kühn K
Z Kardiol; 1985; 74 Suppl 2():103-8. PubMed ID: 4002782
[TBL] [Abstract][Full Text] [Related]
40. Antihypertensive therapy with triamterene-hydrochlorothiazide vs amiloride-hydrochlorothiazide. Comparison of effects on urinary prostaglandin E2 excretion.
Zawada ET
Arch Intern Med; 1986 Jul; 146(7):1312-4. PubMed ID: 3521523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
